Physiological studies with human leukocyte inhibitory factor
- PMID: 1504141
Physiological studies with human leukocyte inhibitory factor
Abstract
LIF has been shown to be a potentially important activator of neutrophil function. By means of its dose-dependent dichotomous effects on chemotaxis, LIF can be predicted to both enhance the potency of chemotactic stimuli and promote the passive accumulation of PMN at inflammatory loci. Furthermore, LIF's stimulatory effects on both PMN- and endothelial cell-mediated adherence will promote the migration of neutrophils from the circulation to the inflammatory site. We have demonstrated LIF stimulation of fMLP, CR1, and CR3 expression and function, as well a stimulated Fc gamma RIII function. Through both receptor-dependent and -independent effects. LIF produces increased target cell attachment, phagocytosis, respiratory burst activity, and degranulation. Together, these effects result in a significant increase in killing of both phagocytosed targets and extracellular targets.
Similar articles
-
Effects of leukocyte inhibitory factor (LIF) on neutrophil phagocytosis and bactericidal activity.J Immunol. 1987 Mar 1;138(5):1475-9. J Immunol. 1987. PMID: 2949016
-
Leukocyte inhibitory factor (LIF) potentiates neutrophil responses to formyl-methionyl-leucyl-phenylalanine.J Immunol. 1986 Sep 15;137(6):1897-903. J Immunol. 1986. PMID: 3018081
-
Leukocyte inhibitory factor (LIF) potentiates human macrophage aggregation and activation responses to calcium ionophore A23187 and directly induces leukotriene B4 and thromboxane A2 release.Biotechnol Ther. 1993;4(3-4):239-52. Biotechnol Ther. 1993. PMID: 8292972
-
Molecular mechanisms involved in the inhibition of neutrophil locomotion by tumor cells.Blood Cells. 1993;19(1):177-84; discussion 185-7. Blood Cells. 1993. PMID: 8400309 Review.
-
Activation of neutrophils by interleukins-1 and -2 and tumor necrosis factors.Immunol Ser. 1992;57:417-36. Immunol Ser. 1992. PMID: 1504143 Review.